These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 30362915

  • 1. Using Previous Medication Adherence to Predict Future Adherence.
    Kumamaru H, Lee MP, Choudhry NK, Dong YH, Krumme AA, Khan N, Brill G, Kohsaka S, Miyata H, Schneeweiss S, Gagne JJ.
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1146-1155. PubMed ID: 30362915
    [Abstract] [Full Text] [Related]

  • 2. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
    Majd Z, Mohan A, Paranjpe R, Abughosh SM.
    J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
    [Abstract] [Full Text] [Related]

  • 3. Predicting 1-Year Statin Adherence Among Prevalent Users: A Retrospective Cohort Study.
    Krumme AA, Franklin JM, Isaman DL, Matlin OS, Tong AY, Spettell CM, Brennan TA, Shrank WH, Choudhry NK.
    J Manag Care Spec Pharm; 2017 Apr; 23(4):494-502. PubMed ID: 28345442
    [Abstract] [Full Text] [Related]

  • 4. Utilization Patterns of Oral Disease-Modifying Drugs in Commercially Insured Patients with Multiple Sclerosis.
    Desai RJ, Mahesri M, Gagne JJ, Hurley E, Tong A, Chitnis T, Minden S, Spettell CM, Matlin OS, Shrank WH, Choudhry NK.
    J Manag Care Spec Pharm; 2019 Jan; 25(1):113-121. PubMed ID: 30589630
    [Abstract] [Full Text] [Related]

  • 5. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending.
    Brixner D, Rubin DT, Mease P, Mittal M, Liu H, Davis M, Ganguli A, Fendrick AM.
    J Manag Care Spec Pharm; 2019 Jul; 25(7):770-779. PubMed ID: 31081461
    [Abstract] [Full Text] [Related]

  • 6. Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit.
    Fendrick AM, Brixner D, Rubin DT, Mease P, Liu H, Davis M, Mittal M.
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1086-1095. PubMed ID: 33843252
    [Abstract] [Full Text] [Related]

  • 7. Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk.
    Lin I, Sung J, Sanchez RJ, Mallya UG, Friedman M, Panaccio M, Koren A, Neumann P, Menzin J.
    J Manag Care Spec Pharm; 2016 Jun; 22(6):685-98. PubMed ID: 27231796
    [Abstract] [Full Text] [Related]

  • 8. Actionable Real-World Evidence to Improve Health Outcomes and Reduce Medical Spending Among Risk-Stratified Patients with Diabetes.
    Garry EM, Schneeweiss S, Eapen S, Petruski-Ivleva N, Cheever E, Murk W, Rajan A, Rassen JA, Gambino D, Jang H, Rubin E, Jan S.
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1442-1452. PubMed ID: 31778623
    [Abstract] [Full Text] [Related]

  • 9. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications.
    Axon DR, Vaffis S, Chinthammit C, Lott BE, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ.
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989
    [Abstract] [Full Text] [Related]

  • 10. Development and validation of a drug adherence index for COPD.
    Bengtson LGS, Bancroft T, Schilling C, Buikema AR, Stanford RH.
    J Manag Care Spec Pharm; 2021 Feb; 27(2):198-209. PubMed ID: 33506734
    [Abstract] [Full Text] [Related]

  • 11. Enhancing Statin Adherence Using a Motivational Interviewing Intervention and Past Adherence Trajectories in Patients with Suboptimal Adherence.
    Abughosh SM, Vadhariya A, Johnson ML, Essien EJ, Esse TW, Serna O, Gallardo E, Boklage SH, Choi J, Holstad MM, Fleming ML.
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1053-1062. PubMed ID: 31556824
    [Abstract] [Full Text] [Related]

  • 12. Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects.
    Smith MR, Sandhu S, George DJ, Chi KN, Saad F, Thiery-Vuillemin A, Stàhl O, Olmos D, Danila DC, Gafanov R, Castro E, Moon H, Joshua AM, Mason GE, Espina BM, Liu Y, Lopez-Gitlitz A, Francis P, Bevans KB, Fizazi K.
    J Manag Care Spec Pharm; 2023 Jul; 29(7):758-768. PubMed ID: 37404070
    [Abstract] [Full Text] [Related]

  • 13. Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors.
    Lauffenburger JC, Franklin JM, Krumme AA, Shrank WH, Matlin OS, Spettell CM, Brill G, Choudhry NK.
    J Manag Care Spec Pharm; 2018 May; 24(5):469-477. PubMed ID: 29694288
    [Abstract] [Full Text] [Related]

  • 14. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model.
    McCormick D, Bhatt DL, Bays HE, Taub PR, Caldwell KA, Guerin CK, Steinhoff J, Ahmad Z, Singh R, Moreo K, Carter J, Heggen CL, Sapir T.
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1517-1528. PubMed ID: 33251993
    [Abstract] [Full Text] [Related]

  • 15. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.
    Holt RIG, Gossage-Worrall R, Hind D, Bradburn MJ, McCrone P, Morris T, Edwardson C, Barnard K, Carey ME, Davies MJ, Dickens CM, Doherty Y, Etherington A, French P, Gaughran F, Greenwood KE, Kalidindi S, Khunti K, Laugharne R, Pendlebury J, Rathod S, Saxon D, Shiers D, Siddiqi N, Swaby EA, Waller G, Wright S.
    Br J Psychiatry; 2019 Feb; 214(2):63-73. PubMed ID: 30251622
    [Abstract] [Full Text] [Related]

  • 16. Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study.
    Chinthammit C, Axon DR, Mollon L, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ.
    J Manag Care Spec Pharm; 2021 Jan; 27(1):64-72. PubMed ID: 33377445
    [Abstract] [Full Text] [Related]

  • 17. Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.
    Bellows BK, Olsen CJ, Voelker J, Wander C.
    J Manag Care Spec Pharm; 2016 Aug; 22(8):892-900. PubMed ID: 27459651
    [Abstract] [Full Text] [Related]

  • 18. Risk of Nondherence to Diabetes Medications Among Medicare Advantage Enrollees: Development of a Validated Risk Prediction Tool.
    Mhatre SK, Serna O, Sansgiry S, Fleming ML, Essien EJ, Sansgiry SS.
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1293-1301. PubMed ID: 27783546
    [Abstract] [Full Text] [Related]

  • 19. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G, Conti V, Merlino L, Catapano AL, Mancia G.
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [Abstract] [Full Text] [Related]

  • 20. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
    Amin K, Farley JF, Maciejewski ML, Domino ME.
    J Manag Care Spec Pharm; 2017 Mar; 23(3):337-345. PubMed ID: 28230447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.